November 21, 2017 10:00 AM ESTUpdated 10:11 AM
News Briefing

Jeff Capel­lo joins Bio­gen as CFO; Tesaro en­ters $500M loan agree­ment; Palatin li­cens­es fe­male li­bido drug to Ko­re­a's Kwang­don

Amber Tong

→ Bio­gen has re­cruit­ed Jeff Capel­lo as CFO and ex­ec­u­tive vice pres­i­dent, fill­ing the po­si­tion a few months af­ter los­ing Paul Clan­cy to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Bris­tol My­ers re­veals more job cuts in New Jer­sey

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Gilead buys ex­per­i­men­tal HIV vac­cines from a small Barcelona biotech

A service from the Financial Times